Patents by Inventor Brian Robley

Brian Robley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230406908
    Abstract: Egg laying birds on egg farms are inoculated with one or more disease antigens from microbial organisms causing infectious diseases. Egg material from the eggs contain one or more avian antibodies against the microbial organisms and these avian antibodies can specifically bind and/or neutralize the microbial organisms upon consumption by individuals in a population. Egg products comprising the one or more avian antibodies are provided to individuals in the population to increase the prevalence of avian antibodies against the microbial organism in the population. The egg products are provided in a variety of formulations for protecting individuals against the disease and/or for reducing the susceptibility for acquiring the disease. Egg products effective against infections of SARS-CoV-2 in individuals and for reducing the incidence of Covid-19 are provided. Methods are provided to decrease the infection rates of infectious diseases in a population of individuals.
    Type: Application
    Filed: October 18, 2021
    Publication date: December 21, 2023
    Inventors: Bradley M. Mitteness, Scott Simplot, Michelle L. Hawkins, Brian Robley, Philip Larson, Jason Hull
  • Publication number: 20210347859
    Abstract: Formulations of egg powders with avian antibodies that act as mucosal protectants are provided. The formulations are effective for protecting the mucosal membranes in the pharyngeal area of an individual from viral infections. Formulations effective for reducing infections of SARS-CoV-2 in individuals are provided. Formulations are also effective for reducing transmission of viral disease. The formulations are tablets, candies, gummies, throat lozenges, and powders for administering to the pharyngeal area. Methods for administering the formulations for reducing viral disease such as Covid-19 are disclosed.
    Type: Application
    Filed: May 6, 2021
    Publication date: November 11, 2021
    Inventors: Scott Simplot, Bradley M. Mitteness, Michelle Hawkins, Jason Hull, Brian Robley, Philip Larson, Michael Brielmaier, Benjamin Willaert, Vergene Harkins